[Effects of tris (2,3-dibromopropyl) phosphate on the prenatal and postnatal developments of the rats (author's transl)].
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D005317:Fetal Growth Retardation / Q000139:chemically induced; D005333:Fetus / Q000187:drug effects*; D008297:Male; D008431:Maternal-Fetal Exchange; D010755:Organophosphates / Q000008:administration & dosage / Q000009:adverse effects*; D009943:Organophosphorus Compounds / Q000009:adverse effects*; D011247:Pregnancy / Q000187:drug effects*; D051381:Rats
D010755:Organophosphates; D009943:Organophosphorus Compounds; C012085:tris(2,3-dibromopropyl)phosphate